The aim of this study is to investigate evidence for NLRP3 inflammasome activation in AD using brain tissue collected at post mortem from moderately and severely affected AD subjects and neuropathologically unaffected control subjects. This evidence concerns the gene NLRP3 and Alzheimer disease.